Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Laing

Showing results (161-170 of 172) with videos related to

Pageof 18
Sort By:
Open Forum Infectious Diseases|December 15, 2021
COVID-19 Outcomes Among US Military Health System Beneficiaries Include Complications Across Multiple Organ Systems and Substantial Functional ImpairmentStephanie A Richard, Simon D Pollett, Charlotte A Lanteri, et al.
Open Forum Infectious Diseases|January 20, 2022
Adverse Effects and Antibody Titers in Response to the BNT162b2 mRNA COVID-19 Vaccine in a Prospective Study of Healthcare WorkersSi'Ana A Coggins, Eric D Laing, Cara H Olsen, et al.
The Journal of Infectious Diseases|October 21, 2021
Durability of SARS-CoV-2-Specific T-Cell Responses at 12 Months PostinfectionZhongyan Lu, Eric D Laing, Jarina Pena DaMata, et al.
BMC Infectious Diseases|June 10, 2021
Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workersBelinda M Jackson-Thompson, Emilie Goguet, Eric D Laing, et al.
Emerging Infectious Diseases|February 24, 2022
Novel Hendra Virus Variant Detected by Sentinel Surveillance of Horses in AustraliaEdward J Annand, Bethany A Horsburgh, Kai Xu, et al.
Open Forum Infectious Diseases|February 24, 2022
Prospective Assessment of Symptoms to Evaluate Asymptomatic SARS-CoV-2 Infections in a Cohort of Health Care WorkersEmilie Goguet, John H Powers, Cara H Olsen, et al.
Emerging Infectious Diseases|February 24, 2022
Durability of Antibody Response and Frequency of SARS-CoV-2 Infection 6 Months after COVID-19 Vaccination in Healthcare WorkersEric D Laing, Carol D Weiss, Emily C Samuels, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2022
Understanding "Hybrid Immunity": Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) VaccinesNusrat J Epsi, Stephanie A Richard, David A Lindholm, et al.
Cell Host & Microbe|November 10, 2022
Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination historyWei Wang, Sabrina Lusvarghi, Rahul Subramanian, et al.
Nature Communications|February 3, 2023
Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivityWei-Hung Chen, Agnes Hajduczki, Elizabeth J Martinez, et al.
Pageof 18

Showing results (161-170 of 172) with videos related to

Sort By:
Pageof 18
Open Forum Infectious Diseases|December 15, 2021
COVID-19 Outcomes Among US Military Health System Beneficiaries Include Complications Across Multiple Organ Systems and Substantial Functional ImpairmentStephanie A Richard, Simon D Pollett, Charlotte A Lanteri, et al.
Open Forum Infectious Diseases|January 20, 2022
Adverse Effects and Antibody Titers in Response to the BNT162b2 mRNA COVID-19 Vaccine in a Prospective Study of Healthcare WorkersSi'Ana A Coggins, Eric D Laing, Cara H Olsen, et al.
The Journal of Infectious Diseases|October 21, 2021
Durability of SARS-CoV-2-Specific T-Cell Responses at 12 Months PostinfectionZhongyan Lu, Eric D Laing, Jarina Pena DaMata, et al.
BMC Infectious Diseases|June 10, 2021
Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workersBelinda M Jackson-Thompson, Emilie Goguet, Eric D Laing, et al.
Emerging Infectious Diseases|February 24, 2022
Novel Hendra Virus Variant Detected by Sentinel Surveillance of Horses in AustraliaEdward J Annand, Bethany A Horsburgh, Kai Xu, et al.
Open Forum Infectious Diseases|February 24, 2022
Prospective Assessment of Symptoms to Evaluate Asymptomatic SARS-CoV-2 Infections in a Cohort of Health Care WorkersEmilie Goguet, John H Powers, Cara H Olsen, et al.
Emerging Infectious Diseases|February 24, 2022
Durability of Antibody Response and Frequency of SARS-CoV-2 Infection 6 Months after COVID-19 Vaccination in Healthcare WorkersEric D Laing, Carol D Weiss, Emily C Samuels, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2022
Understanding "Hybrid Immunity": Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) VaccinesNusrat J Epsi, Stephanie A Richard, David A Lindholm, et al.
Cell Host & Microbe|November 10, 2022
Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination historyWei Wang, Sabrina Lusvarghi, Rahul Subramanian, et al.
Nature Communications|February 3, 2023
Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivityWei-Hung Chen, Agnes Hajduczki, Elizabeth J Martinez, et al.
Pageof 18